Details of the Drug
General Information of Drug (ID: DMIAUB1)
Drug Name |
Biphenyl-3-ylboronic acid
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
3-Biphenylboronic acid; 5122-95-2; Biphenyl-3-boronic acid; [1,1'-Biphenyl]-3-ylboronic acid; biphenyl-3-ylboronic acid; (3-phenylphenyl)boronic Acid; 3-biphenyl boronic acid; (3-phenylphenyl)boranediol; 3-PHENYLBENZENEBORONIC ACID; (1,1'-biphenyl-3-yl)boronic acid; [1,1'-Diphenyl]-3-ylboronic acid; MFCD01318102; Boronic acid, [1,1'-biphenyl]-3-yl-; AK-35405; Biphenyl-3-boronicacid; PubChem6404; Phenylboronic Acid, 5; Biphenyl-3-bronic acid; 3-biphenyl-boronic acid; ACMC-1AKSL; AC1MC0UE; Biphenyl-3-ylbronic acid
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 |
Molecular Weight | 198.03 | |||||||||||||||||||||
Logarithm of the Partition Coefficient | Not Available | ||||||||||||||||||||||
Rotatable Bond Count | 2 | ||||||||||||||||||||||
Hydrogen Bond Donor Count | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||